ArticleBlood and lymphatic cancer : targets and therapy2026

Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia.

Zixing Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.